Efficacy of intranasal fluticasone furoate for prevention chronic rhinosinusitis in nasopharyngeal carcinoma patient: A randomized controlled trial

Phase 2

Recruiting

• Conditions: Post radiation chronic rhinosinusitis in nasopharyngeal carcinoma patients; Rhinosinusitis; Radiation

• Registration Number: TCTR20210203001
• Lead Sponsor: Mahidol university

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-02-03
• Study Completion: 2022-05-01
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 25

Inclusion Criteria

Nasopharyngeal carcinoma patients age > 18 years who just got the diagnosis and will start radiotherapy

Exclusion Criteria

1. patients who has sinus surgery before
2. patients with rhinosinusitis infection in the past 6 months
3. patients who has been using intranasal corticosteroids before

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Chronic rhinosinusitis 6 months after intervention Lund mackay score

Secondary Outcome Measures

Name	Time	Method
Rhinosinusitis 6 months SNOT22 score